Showing 311-320 of 700 results for "".
Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.Post-Inflammatory Hyperpigmentation in Skin of Color: An Updated Review
https://practicaldermatology.com/topics/pigmentary-disorders/post-inflammatory-hyperpigmentation-in-skin-of-color-an-updated-review/67255/Treatments for PIH involve topical agents, oral agents, and procedures, the selection of which is determined on both depth of PIH and anatomic location.HZ Masquerading as Periorbital Cellulitis Following Mohs Surgery; AMA Focuses on Physician Well-being, Suicide Prevention
https://practicaldermatology.com/youngmd-connect/resident-resource-center/hz-masquerading-as-periorbital-cellulitis-following-mohs-surgery-ama-focuses-on-physician-well-being-suicide-prevention/20374/Muscle Makers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/muscle-makers/23541/The newest body sculpting technologies show promise for building muscle and strength.Effectiveness of Early Moisturizer Use in Atopic Dermatitis Prevention
https://practicaldermatology.com/issues/novemberdecember-2025/effectiveness-of-early-moisturizer-use-in-atopic-dermatitis-prevention/48889/In the 2025 study by Simpson et al entitled “Emollients to Prevent Pediatric Eczema: A Randomized Clinical Trial,” once-daily, full-body emollient use initiated at 9 weeks of age significantly reduced the cumulative incidence of atopic dermatitis (AD) by 24 months.Verrucous Psoriasis
https://practicaldermatology.com/topics/psoriasis/verrucous-psoriasis/27148/Verrucous psoriasis (VP) is a rare subtype of psoriasis most commonly affecting middle-aged to older adults, with fewer than 35 reported cases within the current literature. It is characterized by symmetric wart-like, hyperkeratotic, papillomatous plaques. Treatment options are limited and variable,Update on TB Screening Prior To and During Biologic Treatment
https://practicaldermatology.com/columns/clinical-focus-1/update-on-tb-screening-prior-to-and-during-biologic-treatment/23220/Is annual screening in all patients really neccesary?Acute Contact Urticaria Due To Use of Cocamidopropyl Betaine-Containing Products Confirmed with Patch Testing
https://practicaldermatology.com/topics/other-dermatology/acute-contact-urticaria-due-to-use-of-cocamidopropyl-betaine-containing-products-confirmed-with-patch-testing/24218/A 23-year-old Caucasian woman presented with progressive worsening recurrent symptoms of hives, burning sensation, and pruritus located on the skin of the face, neck, and arms (see Fig 1, Fig 2). These symptoms began following the use of Biolage Matrix shampoo. She started taking antihistamines (lorExtended Half-Life and Long-Acting Biologics for the Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/extended-half-life-and-long-acting-biologics-for-the-treatment-of-psoriasis/60876/Explore the biologic rationale, emerging clinical candidates, and key unanswered questions surrounding extended half-life therapies for psoriatic disease.Expert Panel Consensus on Uniform Nomenclature and Diagnosis for Neuropathic Pruritus
https://practicaldermatology.com/issues/june-2024/expert-panel-consensus-on-uniform-nomenclature-and-diagnosis-for-neuropathic-pruritus/26549/Dr. Peter Lio and colleagues look at a 2023 article working to establish a consensus on uniform nomenclature and diagnosis for neuropathic pruritis.